-
Relato de Caso
Anaphylactic reaction to patent blue dye during sentinel lymph node biopsy in early-stage breast cancer: a case report
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(12):728-732
03-19-2006
Summary
Relato de CasoAnaphylactic reaction to patent blue dye during sentinel lymph node biopsy in early-stage breast cancer: a case report
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(12):728-732
03-19-2006DOI 10.1590/S0100-72032006001200007
Views96Sentinel lymph node biopsy in the treatment of breast cancer has been replacing lymph node resection in early cases. This treatment may be performed with blue dye and/or radiopharmaceuticals. There are reports of allergic reactions to blue dye with different degrees of severity. A case of severe anaphylactic reaction after intradermal injection of patent blue dye was reported in a patient diagnosed with ductal carcinoma in situ. The patent blue dye facilitates the detection of the sentinel lymph node, but there is the risk of triggering anaphylactic reactions. It is recommended the team involved to be very knowledgeable and prepared to diganose and treat this complication.
Key-words AnaphylaxisBreast neoplasmsCarcinoma, intraductal, noninfiltratingCase reportsColoring agentsHypersensitivitySentinel lymph node biopsySee moreViews96
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Summary
Relato de CasoAnaphylactic reaction to patent blue dye during sentinel lymph node biopsy in early-stage breast cancer: a case report
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(12):728-732
03-19-2006DOI 10.1590/S0100-72032006001200007
Views96Sentinel lymph node biopsy in the treatment of breast cancer has been replacing lymph node resection in early cases. This treatment may be performed with blue dye and/or radiopharmaceuticals. There are reports of allergic reactions to blue dye with different degrees of severity. A case of severe anaphylactic reaction after intradermal injection of patent blue dye was reported in a patient diagnosed with ductal carcinoma in situ. The patent blue dye facilitates the detection of the sentinel lymph node, but there is the risk of triggering anaphylactic reactions. It is recommended the team involved to be very knowledgeable and prepared to diganose and treat this complication.
Key-words AnaphylaxisBreast neoplasmsCarcinoma, intraductal, noninfiltratingCase reportsColoring agentsHypersensitivitySentinel lymph node biopsySee moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Coloring agents Archives - Revista Brasileira de Ginecologia e Obstetrícia
